Infants born prematurely frequently develop a form of chronic lung disease known as Bronchopulmonary Dysplasia. Previously, this disease could only be diagnosed clinically and with a low degree of differentiation. Researchers at the Helmholtz Zentrum München and the University Hospital of the Ludwig-Maximilians University – partner in the German Center for Lung Research (DZL) – have now successfully developed a new protocol for identifying neonatal patients with the disease by the use of magnetic resonance imaging (MRI). Their findings have now been published in Thorax.
Between 15 and 30 percent of all preterm babies with a birth weight of less than 1000 grams or who are born before the 32nd week of pregnancy develop Bronchopulmonary Dysplasia. Depending on disease severity, BPD can lead to lung dysfunction that continues into adulthood, and in some cases also leads to death. “Up until now it has only been possible to diagnose according to clinical criteria that only allow for a low degree of differentiation ,” reports Dr. Anne Hilgendorff, head of the working group “Mechanisms of Neonatal Chronic Lung Disease” at the Institute of Lung Biology (ILBD) and the Comprehensive Pneumology Center (CPC) at the Helmholtz Zentrum München and Director of the Center for Comprehensive Developmental Care (CDeCLMU) providing care for high-risk preterm and term neonates at Munich University Hospital (LMU). Dr. Hilgendorff: “Up to now there has been a lack of specific options for assessing structural changes in the lungs while avoiding the harmful effects of radiation, and this has made personalized treatment and follow-up monitoring more difficult.” A new MRT protocol could now close this gap.
Study involving 61 at-risk patients
Source: Read Full Article